Skip Navigation

Britain has greenlit the country's free healthcare system to use a CRISPR gene-editing therapy for sickle cell anaemia that it is hoped will be a complete cure for the genetic disorder.

www.theguardian.com UK medicines regulator approves gene therapy for two blood disorders

MHRA authorises uses of Casgevy as a potential cure for sickle cell disease and beta thalassemia

UK medicines regulator approves gene therapy for two blood disorders
4
4 comments